Citations 2

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Geburtshilfe und Frauenheilkunde | January 2, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1675442

Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5520-5520

10.1200/jco.2018.36.15_suppl.5520